New short route to unsaturated fluoroketonucleosides: Case of 5-fluoro-1-(6-0-acetyl-3,4-di-deoxy-3-fluoro-β-D-glycero-hex-3-eno-pyranos- 2-ulosyl) uracil

Nucleosides, Nucleotides and Nucleic Acids

Volumn 24, Issue 4, 2005, Pages 243-246

  Egron, Marie José ^a   Komiotis, Dimitri ^b   Dorange, Ismet ^c   Herscovici, Jean ^a   Ollapally, Abraham P ^c   Antonakis, Kostas ^a  

^a PSL RESEARCH UNIVERSITY   (France)

^b UNIVERSITY OF THESSALY   (Greece)

^c FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 FLUORO 1 (6 O ACETYL 3,4 DIDEOXY 3 FLUORO BETA DEXTRO GLYCEROHEX 3 ENOPYRANOS 2 ULOSYL)URACIL; ACETIC ACID DERIVATIVE; FLUORINE DERIVATIVE; HYDROXYL GROUP; KETONE DERIVATIVE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ACETYLATION; ARTICLE; DEPROTECTION REACTION; DRUG SYNTHESIS; ELIMINATION REACTION; OXIDATION; REACTION ANALYSIS;

EID: 22044448379     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1081/NCN-59683     Document Type: Article

References (12)

1. Alaoui, M.; Lasnes, C.; Antonakis, K.; Chouroulinkov, I. Absence of genotoxic effects in cells exposed to four ketonucleosides. Mutagenesis 1986, 1, 411-417.
2. Alaoui, M.; Egron, M.J.; Bessodes, M.; Antonakis, K.; Chouroulinkov, I. Relationship between the structure and cytotoxic activity of new unsaturated ketonucleosides on 8 cell lines. Eur. J. Med. Chem. 1987, 22, 305-310.
3. Egron, M.J.; Leclercq, F.; Antonakis, K.; Bennani-Baitil, I.; Frayssinet, C. Synthesis and antineoplastic activity of 3-deoxy-3-fluoro-ketonucleoside derivatives: correlations between structure and biological activity. Carbohydr. Res. 1994, 248, 143-150.
4. Van Aerschot, A.; Herdewijn, P.; Balzarini, J.; Pauwels, R.; De Clercq, E. 3′-Fluoro-2′,3′-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2′- and 3′-fluorinated 2′,3′-dideoxynucleoside analogues. J. Med. Chem. 1989, 32(8), 1743-1749.
5. Blandin, M.; Tran-Dinh-Son; Catlin, J.C.; Guschlbauer, W. Nucleoside conformations. 16. Nuclear magnetic resonance and circular dichroism studies on pyrimidine-2′-fluoro-2′-deoxyribonucleosides. Biochim. Biophys. Acta 1974, 361, 249-253.
6. Morton, G.O.; Lancaster, J.E.; Van Lear, G.E.; Fulmor, W.; Meyer, W.E. The structure of nucleocidin. 3. (A new structure). J. Am. Chem. Soc. 1969, 91(6), 1535-1537.
7. Lipnick, R.L.; Fissekis, J.D. A comparative conformational study of certain 2′-deoxy-2′-fluoro-arabinofur-anosylcytosine nucleosides. Biochim. Biophys. Acta 1980, 608(1), 96-102.
8. Ollapally, A.P.; Dorange, I.; Whitaker, T.L., Jr. 5-Fluoro-1-(3,4- dideoxy-3-fluoro-6-O-trityl-β-D-glycero-hex-3-eno-pyranos-2-ulosyl)uracil: anticancer agent Nucleosides Nucleotides 1999, 18(4&5), 703-705.
9. Komiotis, D.; Delatre, S.; Holt, S.; Ollapally, A.P.; Balzarini, J.; DeClercq, E.; Mazuakil, I. Biologically important nucleosides: a general method of the synthesis of unsaturated ketonucleosides of uracil and its analogs. Nucleosides Nucleotides 1991, 110, 431-455.
10. Leclercq, F.; Antonakis, K. Direct fluorination at positions 3′, 4′ and 6′ of b-D-glucopyranosyl theophylline. Carbohydr. Res. 1989, 193, 307-313.
11. Herscovicil, J.; Antonakis, K. Molecular sieve-assisted oxidations: new methods for carbohydrate derivative oxidations. J. Chem. Soc., Chem. Commun. 1979, 12, 561-563.
12. Egron, M.J.; Dorange, B.I.; Antonakis, K.; Herscovici, J.; Ollapally, A.P. Unsaturated fluoroketonucleosides as anti-cancer agents. The synthesis and biological activity of 5-fluoro-1-(3,4-dideoxy-3-fluoro-6-O-trityl-β-D- glycero-hex-eno-pyranos-2-ulosyl)uracil. Nucleosides Nucleotides 2002, 21(4&5), 327-334.